Woodline Partners’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Woodline Partners’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-73,796	Closed	-$492K	–	706
2023 Q3	$492K	Buy	+73,796	New	+$613K	0.01%	497

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Woodline Partners's PNT Position: Q4 2023 in Review

Woodline Partners sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 73,796 shares — an estimated $492K sold.

Woodline Partners first reported a position in PNT in Q3 2023 and held it in 1 quarter. The position peaked at $492K in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Woodline Partners reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Woodline Partners sold 73,796 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $492K.
Woodline Partners first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2023 and held it in 1 quarter.
Woodline Partners's POINT Biopharma Global Inc. Common Stock position peaked at $492K in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Woodline Partners's 13F filing for Q4 2023, filed 14 Feb 2024.